"There are a whole class of medications that are insulin sensitizers, so perhaps we can develop medications that will allow people to be sensitized to GLP-1s or find formulations of GLP-1, like the longer-acting versions, that avoid the GLP-1 resistance." she said
The Bottom Line Croaie SMGT-GLP-1 Nano Microneedle Patch is not a clinically tested, doctor-endorsed, or FDA-approved treatment for weight loss or blood sugar regulation
"Often, it's something that may have a marginal pathway towards approval, or a really long time toward approval." The patient had been treated with tirzepatide Lilly's own dual-agonist obesity drug, sold as Zepbound, which the FDA approved in 2023 for approximately a year but achieved only moderate weight loss, according to sources familiar with the matter
Nawrockis Expert Recommendation Making an Informed Decision Alternative Weight Management Options What Is Ozempic